GlassScriptPhysician profile
Austin G Cross
NPI 1952905549
$3,790.11
in general payments reported to CMS, 2019-2025
15 companies · $332 in 2025
The $332 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,494 · 2023: $514 · 2024: $1,451 · 2025: $332.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,352 · Travel and Lodging: $944.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,352.46 |
| Travel and Lodging | $944.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rattan and Associates | $2,162.09 | 2022-2024 | |
| Bioventus LLC | $518.81 | 2022-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System, Durolane |
| Stryker Corporation | $332.89 | 2022-2025 | Conextions Tr Tendon Repair System-Implant Mechanism, Pangea, Hoffmann |
| Arthrex, INC. | $224.95 | 2024 | |
| Kerecis Limited | $158.09 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Globus Medical, INC. | $142.44 | 2023-2024 | Ankle Fracture System, Distal Radius II |
| Vericel Corporation | $83.60 | 2023 | Maci |
| Orthofix Medical, INC. | $31.42 | 2025 | Physio-Stim |
| Orthopediatrics Corp. | $27.22 | 2024 | |
| Innovation Technologies INC | $22.79 | 2023 | Irrisept |
| Vertex Pharmaceuticals Incorporated | $22.58 | 2025 | |
| Zimmer Biomet Holdings, INC. | $18.18 | 2023 | Xtrafix |
| Ossur Americas, INC. | $17.09 | 2024 | I-Digits Quantum |
| Urgo Medical North America, LLC | $15.14 | 2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Depuy Synthes Sales INC. | $12.82 | 2023 | Monovisc |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Austin Cross listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.